Patent · US Expired

Use of growth factors to treat drug-inducted neuropathy

US6011004A · kind A · utility

26Cited by

0References

2Claims

0Family size

Assignee

ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY · US

Inventors

John A. Kessler · New Canaan, US
Stuart C. Apfel · West Hempstead, US

Key dates

Filing date	Dec 17, 1996
Grant date	Jan 4, 2000
Priority date	—
Expiry date	Dec 17, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/337
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor .alpha. (TFG-.alpha.), transforming growth factor .beta. (TGF-.beta.) and others to prevent drug-induced neuropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.